This inventor holds 1 USPTO granted patent. Top assignee: Hokuriku Pharmaceutical Co., Ltd.. Active years: 1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1977
Title: Kazunori Nishide: Innovator in Pharmaceutical Chemistry
Introduction
Kazunori Nishide is a prominent inventor based in Katsuyama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as bronchodilators. His work has implications for improving respiratory health and enhancing the quality of life for individuals with respiratory conditions.
Latest Patents
Kazunori Nishide holds a patent for a compound known as Hydroxyl-substituted-2-chloro-.alpha.-(Tert-butylaminomethyl)-benzylalcohol. This compound is characterized by its unique formula and is recognized for its potential use as a bronchodilator. The patent details the process for the production of these compounds, showcasing Nishide's innovative approach to pharmaceutical development. He has 1 patent to his name.
Career Highlights
Nishide is associated with Hokuriku Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development initiatives. His expertise in chemistry and dedication to innovation have positioned him as a key figure in the pharmaceutical industry. His work not only reflects his personal achievements but also contributes to the broader goals of the company.
Collaborations
Throughout his career, Kazunori Nishide has collaborated with notable colleagues, including Yuzuro Yamamoto and Hideo Kato. These collaborations have fostered a dynamic research environment, allowing for the exchange of ideas and the development of groundbreaking pharmaceutical solutions.
Conclusion
Kazunori Nishide's contributions to pharmaceutical chemistry, particularly in the area of bronchodilator compounds, highlight his innovative spirit and commitment to improving health outcomes. His work continues to inspire advancements in the field, making a lasting impact on respiratory health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile